AusCann Group Holdings Ltd (ACNNF)
0.0049
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
AusCann Group Holdings 1 Year Total Returns (Daily): 36.11% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 36.11% |
May 02, 2024 | 36.11% |
May 01, 2024 | 38.89% |
April 30, 2024 | 356.9% |
April 29, 2024 | 356.9% |
April 26, 2024 | 356.9% |
April 25, 2024 | 257.6% |
April 24, 2024 | 356.9% |
April 23, 2024 | 36.11% |
April 22, 2024 | 36.11% |
April 19, 2024 | 36.11% |
April 18, 2024 | 36.11% |
April 17, 2024 | 36.11% |
April 16, 2024 | 36.11% |
April 15, 2024 | 36.11% |
April 12, 2024 | 509.7% |
April 11, 2024 | 509.7% |
April 10, 2024 | 509.7% |
April 09, 2024 | 348.0% |
April 08, 2024 | 348.0% |
April 05, 2024 | -8.16% |
April 04, 2024 | 20.64% |
April 03, 2024 | -16.33% |
April 02, 2024 | -16.33% |
April 01, 2024 | -16.33% |
Date | Value |
---|---|
March 28, 2024 | 3.54% |
March 27, 2024 | 13.64% |
March 26, 2024 | 23.63% |
March 25, 2024 | 23.63% |
March 22, 2024 | 12.50% |
March 21, 2024 | 12.50% |
March 20, 2024 | 296.5% |
March 19, 2024 | 178.2% |
March 18, 2024 | 178.2% |
March 15, 2024 | 340.6% |
March 14, 2024 | 340.6% |
March 13, 2024 | 534.4% |
March 12, 2024 | 1.00K% |
March 11, 2024 | 20.00% |
March 08, 2024 | 700.0% |
March 07, 2024 | 766.7% |
March 06, 2024 | 0.00% |
March 05, 2024 | 1.90K% |
March 04, 2024 | 1.90K% |
March 01, 2024 | -10.71% |
February 29, 2024 | -59.68% |
February 28, 2024 | -59.68% |
February 27, 2024 | -59.68% |
February 26, 2024 | 151.3% |
February 23, 2024 | 151.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-98.73%
Minimum
Oct 24 2022
1.90K%
Maximum
Mar 04 2024
-42.23%
Average
-58.29%
Median
Aug 26 2022
1 Year Total Returns (Daily) Benchmarks
Alterity Therapeutics Ltd | -24.63% |
Kazia Therapeutics Ltd | -77.89% |
Immutep Ltd | 73.54% |
Opthea Ltd | -5.84% |
Mesoblast Ltd | 13.64% |